Back

Lipoprotein(a) as an emerging target for stroke prevention

2 December 2023 (15:05 - 15:20)
Organised by: Logo
Seminar Presentation Part of: New Approaches in Pharmacological Management Stroke Open Access ESC Heart & Stroke 2023 Council on Stroke

About the speaker

Photo
Professor Jemma Hopewell

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Oral Antithrombotic Drugs for Patients with Structural Interventions
Doctor E. Gurol (Boston, US)
Slides Video
Presentation thumbnail
The Future Role of Factor XIa Inhibition
Professor D. Gorog (London, GB)
Slides Video
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
New Approaches in Pharmacological Management

The Event

Event poster

ESC Heart & Stroke 2023

2 December 2023 15:05 CET
You may be interested in
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Session
How can targeting FXI(a) advance antithrombotic therapy for stroke prevention?
27 August 2023
thumbnail
Congress Presentation
Lipid targets in stroke: LDL-C, Lp(a) and triglyceride-rich lipoproteins
24 April 2026
thumbnail
Congress Presentation
Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources